Pilot Studies of Innovative Treatments in Mental Disorders Project

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for pursuing and encouraging the country's biomedical and health-related research studies.

The programs and grants of the NIH are all designed to contribute to the achievement of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.

The program is primarily established in an effort to solicit ideas and studies that can potentially evaluate the feasibility, tolerability, acceptability and safety of novel mechanism drug candidates and promising psychosocial techniques that can all be used for the successful treatment and management of mental disorders.

The funds that will be awarded under this grant can be utilized to support full scale scientific studies and innovative research services concentrating on the pilot testing of pharmacologic agents, medical devices, psychosocial approaches or a combination of any of the following approaches.

  (continued...)

Pilot Studies of Innovative Treatments in Mental Disorders Project
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on health grants and environmental grants.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Developing and Strengthening Services and Systems that Support Family Cohesion and Respond to the Separation of Children in Democratic Republic of Congo
USAID-DRC has established a program entitled Developing and Strengthening Services and Systems that Support Family Cohesion and Respond to the Separation of Children in Democratic Republic of Congo.

---

Minority-Based Community Clinical Oncology Program Groups
In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---